Allied Market Research

Oral Dissolvable Films Market Forecast 2023


Portland, OR -- (SBWIRE) -- 09/18/2017 -- Oral drug delivery is an essential part of drug delivery and pharmaceutical industry. People with a condition called dysphagia (difficulty in swallowing) require oral administration of drugs. Thus, oral thin film medication are developed for swift oral administration of drugs. To improve patient compliance various types of vaccines and hormones are developed by the market players.

Technological advancement in drug discovery and development processes, less bio-availability of solid drugs, and inaccurate dosage by liquid formulations is expected to boost the market growth for Oral Dissolvable Films Market. However, challenges related to drug development and massive research investment required for creation of simple and novel formulation is expected to hinder the market.

Get PDF Brochure of this report:

Comprehensive competitive analysis and profiles of major market players such as MonoSol Rx, Tesa Labtec GmbH, IntelGenX, BioDelivery Sciences, Cynapsus Therapeutics Inc, FFT Medical, Innoteq, Acadia Pharmaceuticals Inc, Neuroderm Ltd., and Transition Therapeutics, Inc. are provided in this report.

Key Benefits :

-The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.

-Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.

-It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

Early buyers will receive 20% customization on this report